Company

Soricimed Biopharma Inc.

Soricimed Biopharma Inc. is a Canadian biotech firm developing peptide-based cancer therapies that target TRPV6 in solid tumors.

About

Founded in 2005, Soricimed Biopharma Inc. is headquartered in Canada and led by CEO Robert Bruce. Its lead product, SOR-C13, binds TRPV6, a calcium channel overexpressed in solid tumor cells, to deliver therapeutic agents. The company has raised USD 0.25 mn in total, most recently in March 2017 led by New Brunswick Innovation Foundation, and plans to advance its pipeline and expand into North America and Europe.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in